Nab-paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis.

Breast Cancer Res Treat · 2013 · PMC3631516 · PMID 23563958

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Although comparisons within the short DFI subgroups failed to reach statistical significance, comparisons among patients with visceral dominant lesions did demonstrate significant differences for ORR.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.